Patrick Fabbio
Chief Financial OfficeratProtara Therapeutics· In proxies 2023–2024
Pay in FY2024-29% from the year before · Protara Therapeutics stock +181.6% the same year
Patrick Fabbio was paid $1.0M in FY2024 (Dec), down 29%. Protara Therapeutics stock rose 181.6% that year.
Pay$100 in the stock at the end of FY22 → $197
Experience
- Protara TherapeuticsPublic company · 3 yr
- Chief Financial Officer2023 – Present · 3 yrStock in role -9%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?